JPRN-UMIN000020811已完成未知
Clinical safety of peptide pulsed dendritic cell vaccine after radiofrequency ablation for hepatocellular carcinoma - Clinical safety of peptide pulsed dendritic cell vaccine after radiofrequency ablation for hepatocellular carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Immunodeficiency
研究者
相似试验
已完成
1 期
Phase I/II study of peptide pulsed dendritic cell vaccination combined with carboplatin and paclitaxel for patients with advanced malignant melanomaunresectable malignant melanomaJPRN-UMIN000006629Keio University, School of Medicine10
已完成
1 期
A clinical study on the safety of dendritic cell vaccine pulsed with neoantigen peptides for malignant tumor.JPRN-UMIN000032981KOUSHIKAI,Non-profitmedicalcorporation5
已完成
1 期
Dendritic cell immunotherapy in hepatitis C virus (HCV)-infected individuals.ACTRN12611001134910Eric J Gowans6
招募中
不适用
Investigate the safety and efficacy of lymphoma immunotherapylymphomaACTRN12611000988954The First Teaching Hospital, Inner Mongolia Medical College30
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.JPRN-jRCTc030190256Goto Shigenori6,000